The global organ preservation market size was valued at USD 291.2 million in 2025 and is projected to grow from USD 311.1 million in 2026 to USD 516.9 million by 2033, at a CAGR of 7.5% from 2026 to 2033. North America held the largest share of 45.3% in the global market in 2025. Market growth is driven by rising demand for organ transplants, technological advancements, an aging population, and proactive government initiatives.
According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants. This significant increase in the elderly population will intensify the demand for effective preservation solutions, particularly for kidney, liver, and heart transplants, as more elderly patients require these critical procedures. Government initiatives further bolster the organ preservation market by enhancing organ donation rates through awareness campaigns and funding. For instance, in February 2023, the Indian Express reported that the Brihanmumbai Municipal Corporation (BMC) allocated approximately USD 924 million to improve healthcare services and raise awareness of organ donation. Such governmental support is vital in driving the need for efficient preservation methods, particularly in emerging markets such as the Asia Pacific, where healthcare expenditures are rising. This convergence of factors is preparing the organ preservation industry for substantial growth in the coming years.
One of the major growth drivers for the market is the increasing adoption of advanced preservation technologies such as hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP). These technologies are increasingly preferred over traditional preservation methods because they help reduce ischemic injury, improve organ assessment, extend preservation time, and increase the utilization of marginal donor organs. The transition from static cold storage to dynamic machine perfusion systems is transforming transplant procedures globally and improving organ transport efficiency.
Advanced perfusion systems are especially gaining traction in heart, liver, and lung transplantation procedures, where maintaining organ functionality during transportation is critical. In 2024, TransMedics Group reported continued expansion in the clinical adoption of its Organ Care System (OCS) platforms for heart, lung, and liver transplantation across transplant centers in the U.S., highlighting the growing acceptance of portable organ perfusion technologies.
Growing government initiatives and organ donation awareness campaigns are also contributing significantly to market expansion. Several countries are strengthening organ donation infrastructure and implementing public awareness programs to reduce transplant waiting lists and improve donor organ availability. In the UK, NHS Blood and Transplant continues to promote nationwide organ donation campaigns and improve transplant logistics infrastructure to enhance donor organ utilization and reduce organ discard rates. Similarly, the U.S. government and United Network for Organ Sharing (UNOS) have expanded efforts focused on improving organ procurement efficiency and transplantation accessibility across the country.
The market is also benefiting from the increasing use of donation after circulatory death (DCD) organs and the growing focus on expanding the donor organ pool. Advanced preservation technologies are enabling transplant centers to successfully preserve and assess marginal donor organs that were previously considered unsuitable for transplantation. In 2025, Mayo Clinic highlighted ongoing advancements in ex vivo organ perfusion and donor organ rehabilitation technologies to improve preservation times and increase transplantation success rates for high-risk donor organs. Such developments are expected to improve donor organ utilization and support long-term market growth.
This product will be delivered within 1-3 business days.
According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants. This significant increase in the elderly population will intensify the demand for effective preservation solutions, particularly for kidney, liver, and heart transplants, as more elderly patients require these critical procedures. Government initiatives further bolster the organ preservation market by enhancing organ donation rates through awareness campaigns and funding. For instance, in February 2023, the Indian Express reported that the Brihanmumbai Municipal Corporation (BMC) allocated approximately USD 924 million to improve healthcare services and raise awareness of organ donation. Such governmental support is vital in driving the need for efficient preservation methods, particularly in emerging markets such as the Asia Pacific, where healthcare expenditures are rising. This convergence of factors is preparing the organ preservation industry for substantial growth in the coming years.
One of the major growth drivers for the market is the increasing adoption of advanced preservation technologies such as hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP). These technologies are increasingly preferred over traditional preservation methods because they help reduce ischemic injury, improve organ assessment, extend preservation time, and increase the utilization of marginal donor organs. The transition from static cold storage to dynamic machine perfusion systems is transforming transplant procedures globally and improving organ transport efficiency.
Advanced perfusion systems are especially gaining traction in heart, liver, and lung transplantation procedures, where maintaining organ functionality during transportation is critical. In 2024, TransMedics Group reported continued expansion in the clinical adoption of its Organ Care System (OCS) platforms for heart, lung, and liver transplantation across transplant centers in the U.S., highlighting the growing acceptance of portable organ perfusion technologies.
Growing government initiatives and organ donation awareness campaigns are also contributing significantly to market expansion. Several countries are strengthening organ donation infrastructure and implementing public awareness programs to reduce transplant waiting lists and improve donor organ availability. In the UK, NHS Blood and Transplant continues to promote nationwide organ donation campaigns and improve transplant logistics infrastructure to enhance donor organ utilization and reduce organ discard rates. Similarly, the U.S. government and United Network for Organ Sharing (UNOS) have expanded efforts focused on improving organ procurement efficiency and transplantation accessibility across the country.
The market is also benefiting from the increasing use of donation after circulatory death (DCD) organs and the growing focus on expanding the donor organ pool. Advanced preservation technologies are enabling transplant centers to successfully preserve and assess marginal donor organs that were previously considered unsuitable for transplantation. In 2025, Mayo Clinic highlighted ongoing advancements in ex vivo organ perfusion and donor organ rehabilitation technologies to improve preservation times and increase transplantation success rates for high-risk donor organs. Such developments are expected to improve donor organ utilization and support long-term market growth.
Global Organ Preservation Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, the analyst has segmented the global organ preservation market report based on solution, organ, preservation technique, and region:Solution Outlook (Revenue, USD Million, 2021-2033)
- University of Wisconsin (UW)
- Custodiol HTK
- Perfadex
- Others
Organ Type Outlook (Revenue, USD Million, 2021-2033)
- Kidneys
- Liver
- Lung
- Heart
- Others
Preservation Technique Outlook (Revenue, USD Million, 2021-2033)
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Organ Presearvation Market Variables, Trends & Scope
Chapter 4. Organ Presearvation Market: Solution Estimates & Trend Analysis
Chapter 5. Organ Presearvation Market: Organ Estimates & Trend Analysis
Chapter 6. Organ Presearvation Market: Preservation Technique Estimates & Trend Analysis
Chapter 7. Organ Presearvation Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- XVIVO
- TransMedics, Inc.
- 21st Century Medicine
- Bridge to Life Ltd.
- Preservation Solutions, Inc.
- Global Transplant Solutions
- Organ Recovery Systems
- CryoLife, Inc. (Artivion, Inc)
- Paragonix Technologies, Inc (Getinge)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | June 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 291.2 Million |
| Forecasted Market Value ( USD | $ 516.9 Million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
